Spots Global Cancer Trial Database for A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Official Title: Zedula Special Drug Use Observational Study "Ovarian Cancer"
Study ID: NCT05021562
Conditions
Interventions
Study Description
Brief Summary: The main aim of this study is to check for side effects from treatment with niraparib. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with ovarian cancer will take capsules of niraparib (Zedula) once a day according to their clinic's standard practice. The study doctors will check for side effects from niraparib for 1 year after treatment starts.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Takeda Selected Site, Tokyo, , Japan
Contact Details
Name: Study Director
Affiliation: Takeda
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
